Dexcom Receives CE Mark Approval for the Dexcom G4 Continuous Glucose Monitoring System
Dexcom, Inc. (NASDAQ: DXCM) today announced that it has received CE Mark (Conformité Européene) approval for its fourth generation continuous glucose monitoring system, the Dexcom G4® system, enabling commercialization of the Dexcom G4 system in the European Union and the countries in Asia and Latin America that recognize the CE Mark.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.